{"nct_id":"NCT02045966","title":"Study to Determine the Potential DDIs When the Daclatasvir/Asunaprevir/BMS-791325 Three Drug Antiviral Combination Tablet (FDC) is Coadministered With a Cocktail of Cytochrome P450 (CYP) Probe Substrates and Transporter Probe Substrates (Digoxin and Pravastatin) in Healthy Subjects","status":"COMPLETED","status_verified_date":"2014-06","start_date":"2014-02","start_date_type":null,"primary_completion_date":"2014-04","primary_completion_date_type":"ACTUAL","completion_date":"2014-04","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["BMY"]}